tris(chloroethyl)phosphate has been researched along with Metabolic Diseases in 1 studies
*Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Du, H; Fan, X; Gu, N; Hu, H; Oh, Y; Wei, X; Yang, D; Zhang, B; Zhang, Z; Zhao, M; Zhu, R | 1 |
1 other study(ies) available for tris(chloroethyl)phosphate and Metabolic Diseases
| Article | Year |
|---|---|
Probiotics protect against hepatic steatosis in tris (2-chloroethyl) phosphate-induced metabolic disorder of mice via FXR signaling.
Topics: Animals; Flame Retardants; Lipids; Metabolic Diseases; Mice; Obesity; Organophosphates; Phosphates; Phosphines; PPAR alpha; PPAR gamma; Probiotics; Signal Transduction | 2022 |